| Clinical data | |
|---|---|
| Other names | RU41656; 6-Methyl-8-[(methylthio)methyl]-9-oxaergoline |
| Drug class | Dopamine D2 receptor agonist |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C16H20N2OS |
| Molar mass | 288.41 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Voxergolide (INNTooltip International Nonproprietary Name; developmental code name RU-41656), also known as 6-methyl-8-[(methylthio)methyl]-9-oxaergoline, is a dopamine receptor agonist of the 9-oxaergoline family described as an anti-anoxic and anti-ischemic agent which was never marketed. It acts specifically as a dopamine D2 receptor agonist.
| Ergolines (incl. lysergines) |
|
|---|---|
| Clavines (6,8-dimethylergolines) | |
| Lysergamides (lysergic acid amides) |
|
| Ergopeptines (peptide ergolines) |
|
| Partial ergolines |
|
| Related compounds | |
| Natural sources |
|